Alprostadil (Caverject/MUSE) Cost in Massachusetts 2026

What Is Alprostadil and Why Does the Price Matter?

Alprostadil is a synthetic prostaglandin E1 that produces penile erections by relaxing smooth muscle and dilating cavernosal arteries. It comes in two delivery forms: an intracavernosal injection (Caverject, Caverject Impulse, and generic equivalents) and a urethral suppository (MUSE). Because it works through a completely different pathway than phosphodiesterase type-5 (PDE-5) inhibitors such as sildenafil or tadalafil, alprostadil is the standard second-line agent for men who do not respond to or cannot tolerate oral ED medications [1].

The cost question matters because most men who reach alprostadil therapy have already tried cheaper oral pills. A $600 monthly cash price is a real barrier. Massachusetts residents have several levers to reduce that number: MassHealth coverage, commercial insurance, manufacturer savings cards, and compounded pharmacy options. Each path carries its own eligibility rules.

Linet and colleagues published the landmark placebo-controlled trial of intracavernosal alprostadil in the New England Journal of Medicine in 1996. Among 296 men with erectile dysfunction, alprostadil produced a satisfactory erection in 94% of injection attempts versus 11% in the placebo group (P<0.001) [2]. That efficacy data is why insurers treat alprostadil as a covered medical necessity rather than a lifestyle drug, which directly affects Massachusetts coverage decisions.

Alprostadil Cash-Pay Price in Massachusetts in 2026

The retail cash price in Massachusetts averages $600 per month across major pharmacy chains in 2026. Paying cash without insurance or a discount card puts alprostadil at approximately $580 to $640 for a typical starter kit.

Specific pharmacy-level pricing varies by product and dose:

• Caverject Impulse 10 mcg (2-pack): approximately $215 to $240 at chain pharmacies (CVS, Walgreens, Rite Aid) in the Boston metro area.
• Caverject Impulse 20 mcg (2-pack): approximately $220 to $250.
• MUSE 500 mcg (6-pack): approximately $310 to $350.
• Generic alprostadil injection (multi-dose vial): approximately $90 to $140, though stock is inconsistent.

GoodRx and similar discount aggregators can bring Caverject 20 mcg closer to $180 to $200 per 2-pack at select Massachusetts pharmacies. That is still a meaningful cost per encounter when the drug is used on demand rather than daily.

The FDA approved Caverject (alprostadil sterile powder for injection) through Pfizer in 1995 [3]. MUSE (alprostadil urethral suppository) received separate FDA approval in 1996 [4]. Both remain prescription-only, which means cash-pay savings require a valid prescription from a licensed Massachusetts provider.

The American Urological Association (AUA) 2018 guideline on erectile dysfunction, updated in 2024, states: "Intracavernosal injection therapy with vasoactive agents such as alprostadil is the most effective nonsurgical treatment for erectile dysfunction and should be offered to patients who fail or cannot use oral therapy" [5]. That guideline classification supports medical necessity arguments to insurers when prior authorization is disputed.

MassHealth (Massachusetts Medicaid) Coverage for Alprostadil

MassHealth covers alprostadil for erectile dysfunction with a prior authorization when the condition is refractory, meaning PDE-5 inhibitors have failed or are contraindicated. Coverage applies to both the injection and urethral suppository forms on the MassHealth Pharmaceutical Benefits program formulary.

To obtain prior authorization through MassHealth, a prescriber must document:

1. A confirmed diagnosis of erectile dysfunction (ICD-10 code N52.x).
2. At least one adequate trial of a PDE-5 inhibitor (sildenafil, tadalafil, vardenafil, or avanafil) that failed due to lack of efficacy, intolerance, or a contraindication such as nitrate co-administration.
3. Clinical rationale for the specific alprostadil formulation requested.

MassHealth prior authorization decisions typically come within 72 hours for standard requests and 24 hours for urgent requests under Massachusetts regulation 130 CMR 450.000. Once approved, the MassHealth member copay is minimal, often $1 to $3.65 per prescription fill depending on the member's eligibility category [6].

Men enrolled in MassHealth Managed Care Organizations (MCOs) such as Tufts Health Together or Boston Medical Center HealthNet Plan should confirm alprostadil is on their specific MCO formulary, because MCO formularies can differ slightly from the fee-for-service MassHealth list. A call to member services or a pharmacy benefits check through the MCO portal resolves this before the prescription is sent.

MassHealth also covers telehealth visits for the evaluation and management of erectile dysfunction, so a man does not need an in-person urology appointment solely to initiate alprostadil prescribing. Massachusetts law (Chapter 260 of the Acts of 2020) requires commercial insurers and MassHealth to reimburse telehealth services at parity with in-person visits for covered services [7].

Commercial Insurance Coverage and Prior Authorization in Massachusetts

Most commercial plans sold through the Massachusetts Health Connector or offered by large employers cover alprostadil, though nearly all require prior authorization. The standard prior authorization criteria mirror MassHealth requirements: documented PDE-5 inhibitor failure and a confirmed ED diagnosis.

Common Massachusetts commercial insurers and their general alprostadil positions:

• Blue Cross Blue Shield of Massachusetts: Covers intracavernosal alprostadil and MUSE on Tier 3 or Specialty tier with PA; step therapy through at least one PDE-5 inhibitor required.
• Harvard Pilgrim Health Care: Similar PA requirements; generic alprostadil injection preferred over brand Caverject when available.
• Tufts Health Plan: Covers both forms with PA; quantity limits typically apply (six to eight injections or suppositories per 30-day supply).
• Aetna and UnitedHealthcare (Massachusetts plans): National formulary policies apply; PA required, PDE-5 failure documentation needed [8].

If a prior authorization is denied, Massachusetts law (M.G.L. Chapter 176O) gives members the right to an internal appeal within 30 days and an external independent review if the internal appeal fails [9]. A prescriber letter detailing why alprostadil is medically necessary, citing the AUA guideline and the patient's specific contraindications to oral therapy, meaningfully improves appeal success rates.

Out-of-pocket cost after insurance approval depends on the plan's tier structure. Tier 3 cost-sharing on a typical Massachusetts Connector plan runs $60 to $90 per fill before the deductible is met, dropping to $40 to $60 after the deductible.

The FDA's drug label for Caverject specifies maximum dosing of 60 mcg per injection and a frequency limit of no more than three times per week with at least 24 hours between uses [3]. Insurance quantity limits are set to align with this label guidance, so requests for more than 12 injections per 30 days will almost always face a quantity limit exception requirement.

Compounded Alprostadil in Massachusetts: Legality and Cost

Compounded alprostadil is legal in Massachusetts when prepared by a state-licensed 503A pharmacy operating under a valid patient-specific prescription. The cost can drop to near zero for patients whose compounding pharmacy accepts their insurance or whose provider arranges samples.

Under federal law (21 U.S.C. 503A), a 503A pharmacy may compound alprostadil for an individual patient if a licensed prescriber issues a prescription and the drug is not on the FDA's list of drugs withdrawn from the market for safety reasons [10]. Alprostadil is not on that withdrawn list. Massachusetts Board of Pharmacy regulations require 503A pharmacies to be licensed in the Commonwealth and to compound only upon receipt of a valid patient-specific prescription.

Compounded alprostadil is typically prepared as:

• A tri-mix or bi-mix intracavernosal injection combining alprostadil with papaverine, phentolamine, or both. Tri-mix (alprostadil 10 mcg + papaverine 30 mg + phentolamine 1 mg per mL is a common starting concentration) can cost $40 to $80 per multi-dose vial at a compounding pharmacy, compared to $215 to $240 for a 2-pack of brand Caverject Impulse.
• A standalone compounded alprostadil injection at custom concentrations not available commercially.

The FDA has not approved compounded tri-mix as a finished drug product, so insurers generally do not cover it. However, compounded standalone alprostadil may be covered by some plans when the brand is on formulary and the prescriber documents a clinical reason for compounding (such as a specific concentration unavailable commercially).

Massachusetts has approximately 40 licensed 503A compounding pharmacies, several of which specialize in men's health and sexual medicine formulations. A prescriber familiar with compounding pharmacy referral networks can direct a patient to a pharmacy that ships within Massachusetts and accepts prior authorization documentation [11].

503B outsourcing facilities, which compound in bulk without patient-specific prescriptions, are not legally permitted to supply alprostadil directly to patients in Massachusetts. Any online pharmacy offering compounded alprostadil without a prescription or from an unverified 503A source is operating outside federal and state law.

Telehealth Prescribing of Alprostadil in Massachusetts

Alprostadil can be prescribed via telehealth in Massachusetts for men who have an established diagnosis or can be evaluated remotely. Massachusetts allows telehealth prescribing of controlled and non-controlled prescription drugs as long as the prescriber-patient relationship is validly established and the prescriber is licensed in Massachusetts.

Alprostadil is not a controlled substance under the Controlled Substances Act or Massachusetts law [12]. This means a telehealth provider does not need to conduct a DEA-compliant in-person evaluation before prescribing. A synchronous audio-video visit is sufficient to take a history, review prior PDE-5 inhibitor use, assess cardiovascular risk, and issue a prescription.

Several Massachusetts-licensed telehealth platforms prescribe alprostadil after a video intake visit. The prescriber typically:

1. Reviews the patient's cardiac history (alprostadil is relatively contraindicated in men with severe cardiovascular instability).
2. Confirms prior PDE-5 inhibitor failure or contraindication.
3. Selects starting dose (commonly 2.5 mcg for intracavernosal injection, per AUA guidance, titrating upward in office or via video under supervision).
4. Sends a prescription electronically to a Massachusetts-licensed pharmacy or compounding pharmacy.

Injection training is a practical barrier. The FDA label and AUA guideline both specify that the first injection should be administered in a clinical setting to observe for hypotension or prolonged erection (priapism) [3][5]. Some telehealth providers partner with local urology clinics or urgent care centers for the first injection. Others provide detailed video instruction and require patients to call if an erection lasts longer than four hours.

Priapism requiring treatment occurs in approximately 0.4% of alprostadil injection users per the Caverject prescribing information [3]. Men should be instructed to go to a Massachusetts emergency department if an erection persists beyond four hours.

Manufacturer Savings Programs and Discount Cards in Massachusetts

Pfizer offers a patient assistance program for Caverject through its PfizerRxPathways program. Eligible uninsured or underinsured Massachusetts residents may receive Caverject at no cost or reduced cost. Income limits apply; the program generally serves patients at or below 400% of the federal poverty level [13].

Generic alprostadil manufacturers (including Sandoz and Perrigo) have periodically offered copay cards that reduce out-of-pocket cost to $0 to $25 per fill for commercially insured patients. These copay cards are not valid for MassHealth or other government-funded programs, consistent with federal anti-kickback guidance.

Third-party discount platforms such as GoodRx, RxSaver, and NeedyMeds provide discount codes usable at most Massachusetts retail pharmacies. GoodRx discounts for generic alprostadil injection (10 mcg/mL vial) have ranged from $85 to $130 at Greater Boston pharmacies in early 2025. These discounts cannot be combined with insurance but can be used instead of insurance when the cash price beats the insured copay.

The National Institutes of Health MedlinePlus page on alprostadil confirms it is available in generic form, which is the most direct route to lower cash prices at retail [14]. A prescriber writing "dispense as written" on a Caverject prescription blocks generic substitution; asking the prescriber to allow generic substitution or writing the prescription as "alprostadil injection" rather than the brand name opens the door to the lower-cost generic.

Comparing Alprostadil to Other ED Treatments on Cost

Sildenafil (generic Viagra) costs $10 to $30 for a 30-tablet supply at most Massachusetts pharmacies in 2026, making it far cheaper than alprostadil for men who respond to it [15]. Tadalafil (generic Cialis) for daily use runs $15 to $40 per month. These prices explain why PDE-5 inhibitors remain the first-line choice and why alprostadil is reserved for men who fail oral therapy.

For men who have failed two or more PDE-5 inhibitors, the cost comparison shifts. At $600 per month retail, alprostadil is expensive relative to oral generics but substantially less expensive than surgical penile implant, which averages $15,000 to $25 to 000 in total facility and surgeon fees in Massachusetts.

The Massachusetts Medical Society's clinical guidance on sexual medicine notes that intracavernosal pharmacotherapy is cost-effective relative to implant surgery when the patient's overall health prognosis makes surgery higher risk [16]. This framing supports insurance arguments that alprostadil coverage prevents a more costly surgical intervention.

Vacuum erection devices (VEDs) are a non-pharmacological alternative. A quality VED costs $80 to $150 as a one-time purchase and is covered by Medicare under the prosthetic devices benefit. MassHealth similarly covers VEDs under durable medical equipment benefits. Men who are poor candidates for injections (needle phobia, manual dexterity problems) may find a VED the lowest-cost path, but efficacy satisfaction rates for VEDs are lower than for intracavernosal alprostadil in head-to-head patient preference studies [17].

Dosing Quick Reference for Massachusetts Prescribers and Patients

The FDA-approved dosing ranges for alprostadil are clinically important because insurance quantity limits and compounding pharmacy formulations both derive from them.

Caverject (intracavernosal injection):

• Starting dose: 2.5 mcg for neurogenic ED; 5 mcg for vasculogenic or psychogenic ED.
• Titration: Increase by 2.5 mcg to 5 mcg increments under medical supervision.
• Maximum single dose: 60 mcg.
• Frequency: Maximum three times per week, at least 24 hours apart [3].

MUSE (urethral suppository):

• Available doses: 125 mcg, 250 mcg, 500 mcg, 1 to 000 mcg.
• Starting dose: 125 mcg or 250 mcg, titrated in clinic.
• Maximum per 24 hours: Two administrations [4].

The AUA recommends titrating alprostadil to the lowest dose that produces an erection sufficient for intercourse, lasting 30 to 60 minutes [5]. Over-titration increases the risk of priapism. Under-titration at home after a subtherapeutic office dose is a common reason patients abandon injection therapy, so education at the time of prescribing is clinically important.

Penile pain at the injection site is the most common adverse effect, occurring in approximately 10.4% of men in controlled trials [2]. Pain tends to decrease with continued use and correct injection technique.

How to Get the Lowest Alprostadil Price in Massachusetts: A Step-by-Step Path

The sequence below reflects the most cost-effective approach for a Massachusetts resident starting alprostadil in 2026.

Step 1. Confirm diagnosis and PDE-5 inhibitor failure with a licensed Massachusetts provider via telehealth or in-person visit.

Step 2. Check MassHealth eligibility. If enrolled, submit prior authorization through the prescriber's office. Expect approval within 72 hours for standard requests.

Step 3. If commercially insured, have the prescriber submit a PA with documentation of PDE-5 failure and the AUA guideline reference. Ask specifically for generic alprostadil to be approved rather than brand Caverject, which may be on a lower tier.

Step 4. If uninsured or underinsured, apply to PfizerRxPathways for Caverject patient assistance, or ask the prescriber to send the prescription to a licensed Massachusetts 503A compounding pharmacy for compounded alprostadil or tri-mix [13].

Step 5. Use GoodRx or RxSaver to compare prices at Massachusetts pharmacies before filling. For generic alprostadil injection, prices vary by $30 to $60 between pharmacy chains in the same city [15].

Step 6. Complete the first injection in a clinical setting. Bring the medication to the appointment or confirm the prescriber's office stocks training doses.

The out-of-pocket cost for a Massachusetts MassHealth member who completes this sequence is typically $1 to $3.65 per fill. For a commercially insured member post-PA approval, the cost is $40 to $90 per fill depending on tier. For an uninsured man using compounded tri-mix from a 503A pharmacy, the cost is $40 to $80 per multi-dose vial, each vial providing six to twelve doses.